Growth Metrics

Cardlytics (CDLX) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$1.8 million.

  • Cardlytics' Gains from Investment Securities fell 13802.88% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $634000.0, marking a year-over-year decrease of 9728.48%. This contributed to the annual value of -$1.5 million for FY2024, which is 13551.56% down from last year.
  • Latest data reveals that Cardlytics reported Gains from Investment Securities of -$1.8 million as of Q3 2025, which was down 13802.88% from $5.5 million recorded in Q2 2025.
  • Cardlytics' Gains from Investment Securities' 5-year high stood at $19.2 million during Q4 2023, with a 5-year trough of -$65.0 million in Q1 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $141000.0 (2021), whereas its average is -$6.2 million.
  • As far as peak fluctuations go, Cardlytics' Gains from Investment Securities skyrocketed by 89702.38% in 2021, and later crashed by 4623475.18% in 2022.
  • Quarter analysis of 5 years shows Cardlytics' Gains from Investment Securities stood at -$6.4 million in 2021, then tumbled by 120.35% to -$14.0 million in 2022, then soared by 236.95% to $19.2 million in 2023, then crashed by 129.23% to -$5.6 million in 2024, then soared by 67.51% to -$1.8 million in 2025.
  • Its Gains from Investment Securities was -$1.8 million in Q3 2025, compared to $5.5 million in Q2 2025 and $2.6 million in Q1 2025.